Patents by Inventor Maarit Suomalainen

Maarit Suomalainen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alphavirus expression vector
    Patent number: 6692750
    Abstract: The present invention is directed to alphavirus expression vectors comprising at least part of an alphavirus genome and heterologous RNA inserted downstream of an alphavirus base sequence having translation enhancing activity. Such vectors can be used to achieve enhanced levels of expression of DNA or cDNA coding for a desired product and being complementary to said heterologous RNA after introduction of said vector in eukaryotic cells in cell culture or in a living body. The expression product may have therapeutic or prophylactic activity.
    Type: Grant
    Filed: September 7, 2000
    Date of Patent: February 17, 2004
    Assignee: Bioption AB
    Inventors: Mathilda Sjöberg, Maarit Suomalainen, Henrik Garoff
  • Alphavirus expression vector
    Patent number: 6224879
    Abstract: The present invention is directed to alphavirus expression vectors comprising at least part of an alphavirus genome and heterologous RNA inserted downstream of an alphavirus base sequence having translation enhancing activity. Such vectors can be used to achieve enhanced levels of expression of DNA or cDNA coding for a desired product and being complementary to said heterologous RNA after introduction of said vector in eukaryotic cells in cell culture or in a living body. The expression product may have therapeutical or prophylactic activity.
    Type: Grant
    Filed: November 18, 1996
    Date of Patent: May 1, 2001
    Assignee: Bioption AB
    Inventors: Mathilda Sjöberg, Maarit Suomalainen, Henrik Garoff